These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 25457227)

  • 1. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.
    Skoglund C; Chen Q; Franck J; Lichtenstein P; Larsson H
    Biol Psychiatry; 2015 May; 77(10):880-6. PubMed ID: 25457227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden.
    Ljung T; Chen Q; Lichtenstein P; Larsson H
    JAMA Psychiatry; 2014 Aug; 71(8):958-64. PubMed ID: 24964928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.
    Yule AM; Martelon M; Faraone SV; Carrellas N; Wilens TE; Biederman J
    J Psychiatr Res; 2017 Feb; 85():49-55. PubMed ID: 27835739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.
    Biederman J; Petty CR; Wilens TE; Fraire MG; Purcell CA; Mick E; Monuteaux MC; Faraone SV
    Am J Psychiatry; 2008 Jan; 165(1):107-15. PubMed ID: 18006872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
    Wimberley T; Agerbo E; Horsdal HT; Ottosen C; Brikell I; Als TD; Demontis D; Børglum AD; Nordentoft M; Mors O; Werge T; Hougaard D; Bybjerg-Grauholm J; Hansen MB; Mortensen PB; Thapar A; Riglin L; Langley K; Dalsgaard S
    Addiction; 2020 Jul; 115(7):1368-1377. PubMed ID: 31803957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Ottosen C; Petersen L; Larsen JT; Dalsgaard S
    J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.
    Nogueira M; Bosch R; Valero S; Gómez-Barros N; Palomar G; Richarte V; Corrales M; Nasillo V; Vidal R; Casas M; Ramos-Quiroga JA
    Compr Psychiatry; 2014 Apr; 55(3):639-49. PubMed ID: 24411652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for secondary substance use disorders in people with childhood and adolescent-onset bipolar disorder: opportunities for prevention.
    Kenneson A; Funderburk JS; Maisto SA
    Compr Psychiatry; 2013 Jul; 54(5):439-46. PubMed ID: 23332720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
    Vilar-Ribó L; Sánchez-Mora C; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Arribas L; Casas M; Ramos-Quiroga JA; Ribasés M; Soler Artigas M
    Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):140-150. PubMed ID: 33244849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar disorder and its relation to major psychiatric disorders: a family-based study in the Swedish population.
    Song J; Bergen SE; Kuja-Halkola R; Larsson H; Landén M; Lichtenstein P
    Bipolar Disord; 2015 Mar; 17(2):184-93. PubMed ID: 25118125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder.
    Larsson H; Rydén E; Boman M; Långström N; Lichtenstein P; Landén M
    Br J Psychiatry; 2013 Aug; 203(2):103-6. PubMed ID: 23703314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: a meta-analysis of family genetic studies.
    Faraone SV; Biederman J; Wozniak J
    Am J Psychiatry; 2012 Dec; 169(12):1256-66. PubMed ID: 23212057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
    J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family study of girls with attention deficit hyperactivity disorder.
    Faraone SV; Biederman J; Mick E; Williamson S; Wilens T; Spencer T; Weber W; Jetton J; Kraus I; Pert J; Zallen B
    Am J Psychiatry; 2000 Jul; 157(7):1077-83. PubMed ID: 10873914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled, blindly rated, direct-interview family study of a prepubertal and early-adolescent bipolar I disorder phenotype: morbid risk, age at onset, and comorbidity.
    Geller B; Tillman R; Bolhofner K; Zimerman B; Strauss NA; Kaufmann P
    Arch Gen Psychiatry; 2006 Oct; 63(10):1130-8. PubMed ID: 17015815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.